BioXcel Therapeutics, Inc. (BTAI)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 22, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
BioXcel Therapeutics Market Cap : 34.89M for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Verastem, Inc. | 372.58M |
| Quince Therapeutics, Inc. | 17.93M |
| ACADIA Pharmaceuticals, Inc. | 3.613B |
| Alnylam Pharmaceuticals, Inc. | 39.71B |
| Amgen, Inc. | 183.12B |
Market Cap Related Metrics
| PS Ratio | 24.02 |
| PEG Ratio | -0.0174 |
| Price | 1.13 |
| Earnings Yield | -547.8% |
| PEGY Ratio | -0.0174 |